ICH GCP Goes Risk-Based

by Artem Andrianov, PhD, Beat Widler, PhD, Maria Proupín-Pérez, PhD

Originally published by Applied Clinical Trials Online

Available: http://www.appliedclinicaltrialsonline.com/ich-gcp-goes-risk-based.

By Artem Andrianov, Ph.D., MBA|2016-11-16T18:35:42+02:00October 21, 2015|News|0 Comments

About the Author: Artem Andrianov, Ph.D., MBA

Professional in the integration of data-driven Risk-based Quality Management (RBQM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, Health 2.0, DGGF, etc. 18+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RBQM research to new frontiers for CROs, pharma and biotech companies.